Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in AXGN — Axogen, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to AXGN Full portfolio

Position in AXGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,979,821
+$3,058,775 QoQ
Shares Held
86,162
+209.9% QoQ
Ownership
0.160%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#85
of 253 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AXGN Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $3,532,507,562 across 104 Medical Devices names. AXGN ranks #26 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
 15,177,317 $1,377,189,742
2 SYK
Stryker Corp
 2,407,680 $758,033,968
3 MDT
Medtronic plc
 7,904,930 $618,402,670
4 BSX
Boston Scientific Corp
 3,051,613 $130,242,842
5 EW
Edwards Lifesciences Corp
 1,041,675 $94,229,919
6 GMED
Globus Medical Inc
 996,617 $78,742,707
7 DXCM
Dexcom Inc
 1,011,869 $68,149,375
8 GEHC
GE HealthCare Technologies Inc.
 879,516 $56,297,816

All Filings in AXGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,979,821 86,162
2026-03-31 $921,046 27,801
2025-12-31 $1,950,281 59,587
2025-09-30 $722,608 40,505
2025-06-30 $391,977 36,127
2025-03-31 $614,329 33,207
2024-12-31 $539,884 32,760
2024-09-30 $364,617 26,007
2024-06-30 $346,122 47,807
2024-03-31 $405,799 50,285
2023-12-31 $273,499 40,044
2023-09-30 $183,230 36,646
2023-06-30 $641,090 70,218
2023-03-31 $583,801 61,778
2022-12-31 $538,730 53,981
2022-09-30 $643,488 53,984
2022-06-30 $445,379 54,381
2022-03-31 $602,804 75,920
2021-12-31 $855,901 91,345
2021-09-30 $1,844,570 116,745
2021-06-30 $2,149,826 99,483
2021-03-31 $1,595,454 78,749
2020-12-31 $2,455,270 137,166
2020-09-30 $1,580,050 135,860
2020-06-30 $1,643,267 177,843
2020-03-31 $215,601 20,731